NCT04265911View on ClinicalTrials.gov

Single Ascending Dose of ASP3772 Study in Japanese Healthy Male and Female Adults, and Single Ascending Dose Study of ASP3772 in Comparison With PPSV23 in Japanese Elderly Male and Female Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

126

Participants

Timeline

Start Date

February 19, 2020

Primary Completion Date

November 7, 2020

Study Completion Date

November 7, 2020

Conditions
Healthy Volunteers
Interventions
BIOLOGICAL

ASP3772 (subcutaneous)

Subcutaneous injection

BIOLOGICAL

ASP3772 (intramuscular)

Intramuscular injection

BIOLOGICAL

PPSV23 (subcutaneous)

Subcutaneous injection

BIOLOGICAL

PPSV23 (intramuscular)

Intramuscular injection

Trial Locations (1)

Unknown

JP81001, Fukuoka

Sponsors

Lead Sponsor

Affinivax, Inc.
All Listed Sponsors
lead

Affinivax, Inc.

INDUSTRY

NCT04265911 - Single Ascending Dose of ASP3772 Study in Japanese Healthy Male and Female Adults, and Single Ascending Dose Study of ASP3772 in Comparison With PPSV23 in Japanese Elderly Male and Female Subjects | Biotech Hunter | Biotech Hunter